Cargando…

The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia

Neonatal hypoxia-ischemia (HI) often causes hypoxic-ischemic encephalopathy (HIE), a neurological condition that can lead to overall disability in newborns. The only treatment available for affected neonates is therapeutic hypothermia; however, cooling is not always effective to prevent the deleteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beldarrain, Gorane, Hilario, Enrique, Lara-Celador, Idoia, Chillida, Marc, Catalan, Ana, Álvarez-Diaz, Antonia Ángeles, Alonso-Alconada, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300731/ https://www.ncbi.nlm.nih.gov/pubmed/37376115 http://dx.doi.org/10.3390/pharmaceutics15061667

Ejemplares similares

The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
por: Duranti, Andrea, et al.
Publicado: (2022)

Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury
por: Lara-Celador, I., et al.
Publicado: (2013)

Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury
por: de Cerio, Felipe Goñi, et al.
Publicado: (2013)

Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia
por: Alonso-Alconada, Daniel, et al.
Publicado: (2013)

Complete genome sequence of the nitrogen-fixing bacterium Azospirillum humicireducens type strain SgZ-5(T)
por: Yu, Zhen, et al.
Publicado: (2018)

Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia
por: Ziemka-Nalecz, Malgorzata, et al.
Publicado: (2016)

Cannabinoid-mediated Modulation of Oxidative Stress and Early Inflammatory Response after Hypoxia–Ischemia
por: Alonso-Alconada, Daniel, et al.
Publicado: (2020)

Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
por: Kasatkina, Ludmila A., et al.
Publicado: (2021)

Endocannabinoid Signaling is Critical for Habit Formation
por: Hilário, Monica R.F., et al.
Publicado: (2007)

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
por: Mounsey, Ross B., et al.
Publicado: (2015)

A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of inhibition
por: Fox, David, et al.
Publicado: (2010)

Neuroprotective role of lactate in rat neonatal hypoxia-ischemia
por: Roumes, Hélène, et al.
Publicado: (2020)

Neuroprotective, Neurogenic, and Amyloid Beta Reducing Effect of a Novel Alpha 2-Adrenoblocker, Mesedin, on Astroglia and Neuronal Progenitors upon Hypoxia and Glutamate Exposure
por: Melkonyan, Magda M., et al.
Publicado: (2017)

Neurogenic and Neuroprotective Potential of Stem/Stromal Cells Derived from Adipose Tissue
por: Figiel-Dabrowska, Anna, et al.
Publicado: (2021)

Editorial: Neuroprotection in Brain Hypoxia
por: Otero-Losada, Matilde, et al.
Publicado: (2019)

Frequency-Dependent Cannabinoid Receptor-Independent Modulation of Glycine Receptors by Endocannabinoid 2-AG
por: Lozovaya, Natalia, et al.
Publicado: (2011)

The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD
por: Leen, N.A., et al.
Publicado: (2022)

Editorial: Brain Hypoxia and Ischemia: New Insights Into Neurodegeneration and Neuroprotection
por: Nalivaeva, Natalia N., et al.
Publicado: (2019)

Contribution of Oxidative Stress and Inflammation to the Neurogenic Hypertension Induced by Intermittent Hypoxia
por: Oyarce, María P., et al.
Publicado: (2018)

A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action
por: Chakravarty, Sumana, et al.
Publicado: (2015)

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
por: Fagundo, Ana B., et al.
Publicado: (2013)

Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats
por: Arteaga, Olatz, et al.
Publicado: (2015)

Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy
por: Poupon-Bejuit, Laura, et al.
Publicado: (2020)

Microglia and Stem-Cell Mediated Neuroprotection after Neonatal Hypoxia-Ischemia
por: Brégère, Catherine, et al.
Publicado: (2021)

Neuroprotective effect of Src kinase in hypoxia-ischemia: A systematic review
por: Christidis, Panagiotis, et al.
Publicado: (2022)

Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans
por: Rothner, Ariel, et al.
Publicado: (2023)

Hypoxia Induces DPSC Differentiation versus a Neurogenic Phenotype by the Paracrine Mechanism
por: Delle Monache, Simona, et al.
Publicado: (2022)

The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica
por: Pellkofer, Hannah L., et al.
Publicado: (2013)

Neuroprotective effects of hypothermia and levetiracetam after hypoxia-ischemia in the neonatal mouse brain
por: Straßer, Katja, et al.
Publicado: (2014)

NIR Laser Photobiomodulation Induces Neuroprotection in an In Vitro Model of Cerebral Hypoxia/Ischemia
por: Gerace, Elisabetta, et al.
Publicado: (2021)

Neuroprotective Effect of Eco-Sustainably Extracted Grape Polyphenols in Neonatal Hypoxia-Ischemia
por: Roumes, Hélène, et al.
Publicado: (2022)

Editorial: Brain hypoxia and ischemia: New insights into neurodegeneration and neuroprotection, volume II
por: Nalivaeva, Natalia N., et al.
Publicado: (2023)

Hypoxia, hibernation and Neuroprotection: An Experimental Study in Mice
por: Ren, Changhong, et al.
Publicado: (2018)

Neuroprotective Role of Akt in Hypoxia Adaptation in Andeans
por: Zhao, Helen, et al.
Publicado: (2021)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment
por: Benny, Feba, et al.
Publicado: (2023)

Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes
por: Serrano, Antonia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhtfqc0p8k8ehv9p6s6mpfmpbm